Delineation of neck node levels for patients with locally advanced supraglottic cancer receiving radical intensity-modulated radiotherapy: a cross-sectional study in Mainland China

被引：0

作者：

Xu, Yi ^{[1
]}

He, Meilin ^{[1
]}

Liu, Yang ^{[1
]}

Wang, Zekun ^{[1
]}

Yi, Junlin ^{[1
,2
]}

Zhang, Ye ^{[1
]}

机构：

[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Radiat Oncol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China

[2] Chinese Acad Med Sci, Natl Canc Ctr, Dept Radiat Oncol, Natl Clin Res Ctr Canc,Hebei Canc Hosp, Langfang 065001, Peoples R China

来源：

FUTURE ONCOLOGY | 2022年 / 18卷 / 22期

关键词：

cross-sectional study; locally advanced supraglottic cancer; lymph node clinical target volumes; radical radiotherapy; SQUAMOUS-CELL CARCINOMA; LYMPH-NODE; HEAD; METASTASIS; INVOLVEMENT; DISSECTION; DAHANCA; LARYNX; RISK; IIB;

D O I：

10.2217/fon-2022-0004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: To survey the diversity of clinical target volumes (CTVs) for locally advanced supraglottic cancer (LA-SGC) with radical radiotherapy in mainland China. Methods: Radiation oncologists from 30 provinces and four representative cases (T2N1, T3N2b, T4N0, T4N2c) were included. Results: High risk (HR)-CTV included involved and the lower adjacent level was followed by most physicians (n = 160, 97.6%). In the N0-1 stage, whether contralateral levels II-III should be included in HR- or low risk (LR)-CTV was controversial. In the N2 stage, the bilateral levels II-IVb were included in LR-CTV (75-92.5% agreement). Levels Ib, V or VIb were included in CTV requiring certain conditions. Conclusion: Involved and lower adjacent levels were as HR-CTV. Whether bilateral levels II-IV are included in HR- or LR-CTV remain controversial.

引用

页码：2475 / 2482

页数：8

共 30 条

[1] Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update [J].

Biau, Julian ;

Lapeyre, Michel ;

Troussier, Idriss ;

Budach, Wilfried ;

Giralt, Jordi ;

Grau, Cai ;

Kazmierska, Joanna ;

Langendijk, Johannes A. ;

Ozsahin, Mahmut ;

O'Sullivan, Brian ;

Bourhis, Jean ;

Gregoire, Vincent .

RADIOTHERAPY AND ONCOLOGY, 2019, 134 :1-9

[2] A novel classification scheme for advanced laryngeal cancer midline involvement: implications for the contralateral neck [J].

Boettcher, Arne ;

Olze, Heidi ;

Thieme, Nadine ;

Stromberger, Carmen ;

Sander, Steffen ;

Muenscher, Adrian ;

Bier, Johannes ;

Knopke, Steffen .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (08) :1605-1612

[3] Cancer Statistics in China, 2015 [J].

Chen, Wanqing ;

Zheng, Rongshou ;

Baade, Peter D. ;

Zhang, Siwei ;

Zeng, Hongmei ;

Bray, Freddie ;

Jemal, Ahmedin ;

Yu, Xue Qin ;

He, Jie .

CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132

[4] Levels II and III neck dissection for larynx cancer with N0 neck [J].

Chone, Carlos Takahiro ;

Kohler, Hugo Fontana ;

Magalhaes, Rodrigo ;

Navarro, Marcos ;

Altemani, Albina ;

Crespo, Agricio Nubiato .

BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2012, 78 (05) :59-63

[5]

Danish Head and Neck Cancer Group (DAHANCA), NAT GUID PHAR LAR 20

[6] Involvement of level I neck lymph nodes in advanced squamous carcinoma of the larynx [J].

dos Santos, CR ;

Gonçalves, J ;

Magrin, J ;

Johnson, LFP ;

Ferlito, A ;

Kowalski, LP .

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2001, 110 (10) :982-984

[7] The Necessity of Dissection of Level IIb in Laryngeal Squamous Cell Carcinoma: A Clinical Study [J].

Dundar, Riza ;

Aslan, Hale ;

Ozbay, Can ;

Basoglu, Sinan ;

Guvenc, Isil Adadan ;

Ogredik, Evren Ay ;

Ozturkcan, Sedat ;

Tayfun, Mehmet Ali ;

Katilmis, Huseyin .

OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2012, 146 (03) :390-394

[8]

Gallo O, 2000, HEAD NECK-J SCI SPEC, V22, P386, DOI 10.1002/1097-0347(200007)22:4<386::AID-HED12>3.0.CO

[9]

2-5

[10] Squamous cell carcinoma of the subglottis [J].

Garas, J ;

McGuirt, WF .

AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2006, 27 (01) :1-4

← 1 2 3 →